LEADER 04044oam 2201225zu 450 001 9910698355903321 005 20231121220204.0 035 $a(CKB)3450000000002100 035 $a(SSID)ssj0000622408 035 $a(PQKBManifestationID)11350904 035 $a(PQKBTitleCode)TC0000622408 035 $a(PQKBWorkID)10642093 035 $a(PQKB)10293433 035 $a(WaSeSS)Innodata00029947 035 $a(OCoLC)194304648 035 $a(EXLCZ)993450000000002100 100 $a20160829d2008 uy 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aUtility of monitoring mycophenolic acid in solid organ transplant patients 210 31$a[Place of publication not identified]$cAgency for Healthcare Research and Quality$d2008 215 $a1 online resource 225 0 $aEvidence report/technology assessment Utility of monitoring mycophenolic acid in solid organ transplant patients 300 $aBibliographic Level Mode of Issuance: Monograph 320 $aIncludes bibliographical references. 410 0$aEvidence report/technology assessment ;$vno. 164. 410 0$aAHRQ publication ;$vno. 08-E006. 606 $aMycophenolic acid$xComplications 606 $aTransplantation of organs, tissues, etc 606 $aImmunotherapy 606 $aImmunologic Factors 606 $aTherapeutics 606 $aHost vs Graft Reaction 606 $aInvestigative Techniques 606 $aFatty Acids 606 $aCaproates 606 $aTransplantation 606 $aImmunologic Techniques 606 $aAcids, Acyclic 606 $aTransplantation Immunology 606 $aPhysiological Effects of Drugs 606 $aDiagnostic Techniques and Procedures 606 $aSurgical Procedures, Operative 606 $aImmunomodulation 606 $aLipids 606 $aPharmacologic Actions 606 $aBiological Therapy 606 $aCarboxylic Acids 606 $aOrganic Chemicals 606 $aImmune System Phenomena 606 $aChemical Actions and Uses 606 $aMycophenolic Acid 606 $aImmunosuppression Therapy 606 $aImmunosuppressive Agents 606 $aOrgan Transplantation 606 $aGraft Rejection 606 $aMethods 606 $aDrug Therapy 606 $aHealth & Biological Sciences$2HILCC 606 $aPharmacy, Therapeutics, & Pharmacology$2HILCC 615 0$aMycophenolic acid$xComplications 615 0$aTransplantation of organs, tissues, etc 615 2$aImmunotherapy 615 2$aImmunologic Factors 615 2$aTherapeutics 615 2$aHost vs Graft Reaction 615 2$aInvestigative Techniques 615 2$aFatty Acids 615 2$aCaproates 615 2$aTransplantation 615 2$aImmunologic Techniques 615 2$aAcids, Acyclic 615 2$aTransplantation Immunology 615 2$aPhysiological Effects of Drugs 615 2$aDiagnostic Techniques and Procedures. 615 2$aSurgical Procedures, Operative 615 2$aImmunomodulation 615 2$aLipids 615 2$aPharmacologic Actions 615 2$aBiological Therapy 615 2$aCarboxylic Acids 615 2$aOrganic Chemicals 615 2$aImmune System Phenomena 615 2$aChemical Actions and Uses 615 2$aMycophenolic Acid 615 2$aImmunosuppression Therapy 615 2$aImmunosuppressive Agents 615 2$aOrgan Transplantation 615 2$aGraft Rejection 615 2$aMethods 615 2$aDrug Therapy 615 7$aHealth & Biological Sciences 615 7$aPharmacy, Therapeutics, & Pharmacology 676 $a615/.37 702 $aOremus$b Mark 702 $aZeidler$b Johannes 712 02$aUnited States Agency for Healthcare Research and Quality 801 0$bPQKB 906 $aBOOK 912 $a9910698355903321 996 $aUtility of monitoring mycophenolic acid in solid organ transplant patients$93129501 997 $aUNINA